Literature DB >> 20664471

NANETS consensus guidelines for the diagnosis of neuroendocrine tumor.

Aaron I Vinik1, Eugene A Woltering, Richard R P Warner, Martyn Caplin, Thomas M O'Dorisio, Gregory A Wiseman, Domenico Coppola, Vay Liang W Go.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20664471     DOI： 10.1097/MPA.0b013e3181ebaffd

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  84 in total

1.  In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model.

Authors:  Min-Hui Cui; Craig A Branch; Sean M Cahill; Thomas J Quinn; Asha Adem; Steven K Libutti; Ziqiang Yuan
Journal:  Magn Reson Med       Date:  2014-11-13       Impact factor: 4.668

2.  The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.

Authors:  Meredith Cummins; Nick Pavlakis
Journal:  Ther Adv Med Oncol       Date:  2013-09       Impact factor: 8.168

3.  Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomography.

Authors:  Ka-Kit Wong; Arpit Gandhi; Benjamin L Viglianti; Lorraine M Fig; Domenico Rubello; Milton D Gross
Journal:  World J Radiol       Date:  2016-06-28

Review 4.  Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review.

Authors:  Andrea M Isidori; Emilia Sbardella; Maria Chiara Zatelli; Mara Boschetti; Giovanni Vitale; Annamaria Colao; Rosario Pivonello
Journal:  J Clin Endocrinol Metab       Date:  2015-09       Impact factor: 5.958

Review 5.  Small bowel neuroendocrine tumors: From pathophysiology to clinical approach.

Authors:  Sofia Xavier; Bruno Rosa; José Cotter
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 6.  Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors.

Authors:  Jonathan R Strosberg; George A Fisher; Al B Benson; Lowell B Anthony; Bulent Arslan; John F Gibbs; Edward Greeno; Renuka V Iyer; Michelle K Kim; William J Maples; Philip A Philip; Edward M Wolin; Dasha Cherepanov; Michael S Broder
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 7.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

8.  Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.

Authors:  Elana P Simon; Catherine A Freije; Benjamin A Farber; Gadi Lalazar; David G Darcy; Joshua N Honeyman; Rachel Chiaroni-Clarke; Brian D Dill; Henrik Molina; Umesh K Bhanot; Michael P La Quaglia; Brad R Rosenberg; Sanford M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-21       Impact factor: 11.205

9.  Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors.

Authors:  Christine S Landry; Keith Cavaness; Scott Celinski; John Preskitt
Journal:  Gland Surg       Date:  2014-11

10.  Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of Everolimus.

Authors:  Marianne Pavel; Nicole Unger; Ivan Borbath; Sergio Ricci; Tsann-Long Hwang; Thomas Brechenmacher; Jinhee Park; Fabian Herbst; Jennifer L Beaumont; Oliver Bechter
Journal:  Target Oncol       Date:  2016-10       Impact factor: 4.493
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.